1. The report of clinical statistical studies on registered bladder cancer patients in Japan 1994. Tokyo: Japanese Urological Association; 1997.
2. The report of clinical statistical studies on registered bladder cancer patients in Japan 1995. Tokyo: Japanese Urological Association; 1998.
3. The report of clinical statistical studies on registered bladder cancer patients in Japan 1996. Tokyo: Japanese Urological Association; 2000.
4. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group;Akaza;Cancer Chemother. Pharmacol.,1987
5. Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K and The Japanese Urological Cancer Research Group for Adriamycin/Farmorubicin. Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer. Fifth Study of the Japanese Urological Cancer Research Group for Adriamycin/Farmorubicin. Gan To Kagaku Ryoho 2002;29(1):73–80.